nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2D6—breast cancer	0.0893	0.583	CbGaD
Promethazine—ABCB1—breast cancer	0.0638	0.417	CbGaD
Promethazine—Levomethadyl Acetate—Tamoxifen—breast cancer	0.0328	0.093	CrCrCtD
Promethazine—Methadyl Acetate—Tamoxifen—breast cancer	0.0328	0.093	CrCrCtD
Promethazine—Clofedanol—Toremifene—breast cancer	0.031	0.0879	CrCrCtD
Promethazine—Cyclobenzaprine—Tamoxifen—breast cancer	0.0308	0.0875	CrCrCtD
Promethazine—Orphenadrine—Toremifene—breast cancer	0.03	0.0851	CrCrCtD
Promethazine—Benzphetamine—Toremifene—breast cancer	0.03	0.0851	CrCrCtD
Promethazine—CYP2B6—Thiotepa—breast cancer	0.0289	0.115	CbGbCtD
Promethazine—Diphenhydramine—Toremifene—breast cancer	0.0266	0.0756	CrCrCtD
Promethazine—Dimetacrine—Tamoxifen—breast cancer	0.024	0.068	CrCrCtD
Promethazine—Methadone—Tamoxifen—breast cancer	0.0225	0.0639	CrCrCtD
Promethazine—CYP2C9—Anastrozole—breast cancer	0.0201	0.0803	CbGbCtD
Promethazine—Clofedanol—Tamoxifen—breast cancer	0.0194	0.0552	CrCrCtD
Promethazine—CYP2B6—Raloxifene—breast cancer	0.0193	0.0769	CbGbCtD
Promethazine—Benzphetamine—Tamoxifen—breast cancer	0.0188	0.0534	CrCrCtD
Promethazine—Orphenadrine—Tamoxifen—breast cancer	0.0188	0.0534	CrCrCtD
Promethazine—Promazine—Tamoxifen—breast cancer	0.018	0.051	CrCrCtD
Promethazine—ABCB1—Toremifene—breast cancer	0.0179	0.0713	CbGbCtD
Promethazine—Diphenhydramine—Tamoxifen—breast cancer	0.0167	0.0475	CrCrCtD
Promethazine—CYP2C9—Idarubicin—breast cancer	0.0152	0.0609	CbGbCtD
Promethazine—CYP2D6—Idarubicin—breast cancer	0.0139	0.0557	CbGbCtD
Promethazine—ABCB1—Lapatinib—breast cancer	0.013	0.052	CbGbCtD
Promethazine—CYP2B6—Tamoxifen—breast cancer	0.0127	0.0508	CbGbCtD
Promethazine—CYP2B6—Irinotecan—breast cancer	0.00977	0.039	CbGbCtD
Promethazine—CYP2C9—Capecitabine—breast cancer	0.00835	0.0334	CbGbCtD
Promethazine—ABCB1—Vinorelbine—breast cancer	0.00723	0.0289	CbGbCtD
Promethazine—CYP2D6—Vinorelbine—breast cancer	0.00681	0.0272	CbGbCtD
Promethazine—CYP2C9—Tamoxifen—breast cancer	0.00672	0.0268	CbGbCtD
Promethazine—ABCB1—Tamoxifen—breast cancer	0.00652	0.026	CbGbCtD
Promethazine—ABCB1—Mitoxantrone—breast cancer	0.00636	0.0254	CbGbCtD
Promethazine—CYP2D6—Tamoxifen—breast cancer	0.00615	0.0245	CbGbCtD
Promethazine—ABCB1—Gemcitabine—breast cancer	0.00562	0.0224	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—breast cancer	0.00534	0.0213	CbGbCtD
Promethazine—CYP2C9—Paclitaxel—breast cancer	0.00523	0.0209	CbGbCtD
Promethazine—ABCB1—Paclitaxel—breast cancer	0.00508	0.0203	CbGbCtD
Promethazine—ABCB1—Irinotecan—breast cancer	0.00501	0.02	CbGbCtD
Promethazine—CYP2C9—Fluorouracil—breast cancer	0.00495	0.0198	CbGbCtD
Promethazine—ABCB1—Vinblastine—breast cancer	0.00445	0.0178	CbGbCtD
Promethazine—CYP2D6—Vinblastine—breast cancer	0.0042	0.0168	CbGbCtD
Promethazine—ABCB1—Docetaxel—breast cancer	0.00367	0.0147	CbGbCtD
Promethazine—CHRM3—muscle of abdomen—breast cancer	0.00325	0.107	CbGeAlD
Promethazine—ABCB1—Doxorubicin—breast cancer	0.00274	0.0109	CbGbCtD
Promethazine—ABCB1—Methotrexate—breast cancer	0.00265	0.0106	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—breast cancer	0.00258	0.0103	CbGbCtD
Promethazine—HRH4—bone marrow—breast cancer	0.00121	0.0399	CbGeAlD
Promethazine—CALM3—mammary gland—breast cancer	0.000867	0.0285	CbGeAlD
Promethazine—CALM3—nipple—breast cancer	0.000717	0.0236	CbGeAlD
Promethazine—CHRM5—epithelium—breast cancer	0.000692	0.0228	CbGeAlD
Promethazine—CALM1—mammary gland—breast cancer	0.000677	0.0223	CbGeAlD
Promethazine—CHRM5—skin of body—breast cancer	0.000659	0.0217	CbGeAlD
Promethazine—CALM2—nipple—breast cancer	0.000563	0.0185	CbGeAlD
Promethazine—CALM1—nipple—breast cancer	0.00056	0.0185	CbGeAlD
Promethazine—CYP2C9—mammary gland—breast cancer	0.000501	0.0165	CbGeAlD
Promethazine—CALM2—embryo—breast cancer	0.000464	0.0153	CbGeAlD
Promethazine—CALM1—embryo—breast cancer	0.000462	0.0152	CbGeAlD
Promethazine—CALM3—endometrium—breast cancer	0.000433	0.0143	CbGeAlD
Promethazine—HRH1—nipple—breast cancer	0.000409	0.0135	CbGeAlD
Promethazine—Trifluoperazine—S100A4—breast cancer	0.0004	0.138	CrCbGaD
Promethazine—CALM3—uterus—breast cancer	0.000399	0.0131	CbGeAlD
Promethazine—CALM3—pituitary gland—breast cancer	0.000392	0.0129	CbGeAlD
Promethazine—CALM3—adipose tissue—breast cancer	0.00039	0.0128	CbGeAlD
Promethazine—CALM2—epithelium—breast cancer	0.000379	0.0125	CbGeAlD
Promethazine—CALM1—epithelium—breast cancer	0.000377	0.0124	CbGeAlD
Promethazine—CALM2—skin of body—breast cancer	0.00036	0.0119	CbGeAlD
Promethazine—CALM1—skin of body—breast cancer	0.000359	0.0118	CbGeAlD
Promethazine—ADRA1A—epithelium—breast cancer	0.000355	0.0117	CbGeAlD
Promethazine—CALM3—adrenal gland—breast cancer	0.00035	0.0115	CbGeAlD
Promethazine—CALM2—endometrium—breast cancer	0.00034	0.0112	CbGeAlD
Promethazine—CALM3—bone marrow—breast cancer	0.000338	0.0111	CbGeAlD
Promethazine—CALM1—endometrium—breast cancer	0.000338	0.0111	CbGeAlD
Promethazine—CALM3—female gonad—breast cancer	0.000326	0.0107	CbGeAlD
Promethazine—CHRM1—female reproductive system—breast cancer	0.000321	0.0106	CbGeAlD
Promethazine—CALM2—uterus—breast cancer	0.000313	0.0103	CbGeAlD
Promethazine—CHRM3—adipose tissue—breast cancer	0.000313	0.0103	CbGeAlD
Promethazine—CALM1—uterus—breast cancer	0.000312	0.0103	CbGeAlD
Promethazine—CALM2—pituitary gland—breast cancer	0.000308	0.0101	CbGeAlD
Promethazine—CALM2—adipose tissue—breast cancer	0.000306	0.0101	CbGeAlD
Promethazine—CALM1—pituitary gland—breast cancer	0.000306	0.0101	CbGeAlD
Promethazine—CALM1—adipose tissue—breast cancer	0.000305	0.01	CbGeAlD
Promethazine—CHRM2—endocrine gland—breast cancer	0.000299	0.00984	CbGeAlD
Promethazine—CHRM3—female reproductive system—breast cancer	0.000288	0.00947	CbGeAlD
Promethazine—ADRA1A—adipose tissue—breast cancer	0.000287	0.00946	CbGeAlD
Promethazine—DRD2—pituitary gland—breast cancer	0.000283	0.00931	CbGeAlD
Promethazine—HTR2A—embryo—breast cancer	0.000282	0.00928	CbGeAlD
Promethazine—CALM2—female reproductive system—breast cancer	0.000282	0.00927	CbGeAlD
Promethazine—CALM1—female reproductive system—breast cancer	0.00028	0.00923	CbGeAlD
Promethazine—Dimetacrine—ACHE—breast cancer	0.000275	0.095	CrCbGaD
Promethazine—HRH1—epithelium—breast cancer	0.000275	0.00906	CbGeAlD
Promethazine—CALM2—adrenal gland—breast cancer	0.000275	0.00905	CbGeAlD
Promethazine—CALM1—adrenal gland—breast cancer	0.000273	0.00901	CbGeAlD
Promethazine—CHRM1—endocrine gland—breast cancer	0.000272	0.00896	CbGeAlD
Promethazine—CYP2B6—skin of body—breast cancer	0.000268	0.00883	CbGeAlD
Promethazine—CALM2—bone marrow—breast cancer	0.000266	0.00876	CbGeAlD
Promethazine—CALM1—bone marrow—breast cancer	0.000265	0.00872	CbGeAlD
Promethazine—CHRM3—female gonad—breast cancer	0.000262	0.00862	CbGeAlD
Promethazine—ADRA1A—adrenal gland—breast cancer	0.000258	0.00849	CbGeAlD
Promethazine—CALM2—female gonad—breast cancer	0.000256	0.00844	CbGeAlD
Promethazine—CALM1—female gonad—breast cancer	0.000255	0.0084	CbGeAlD
Promethazine—HRH1—endometrium—breast cancer	0.000247	0.00813	CbGeAlD
Promethazine—CHRM3—endocrine gland—breast cancer	0.000243	0.00802	CbGeAlD
Promethazine—CALM2—endocrine gland—breast cancer	0.000238	0.00785	CbGeAlD
Promethazine—CALM1—endocrine gland—breast cancer	0.000237	0.00781	CbGeAlD
Promethazine—HTR2A—epithelium—breast cancer	0.00023	0.00757	CbGeAlD
Promethazine—ADRA1A—endocrine gland—breast cancer	0.000223	0.00736	CbGeAlD
Promethazine—HRH1—adipose tissue—breast cancer	0.000222	0.00733	CbGeAlD
Promethazine—DRD2—endocrine gland—breast cancer	0.000219	0.00722	CbGeAlD
Promethazine—CALM3—lymph node—breast cancer	0.00021	0.00691	CbGeAlD
Promethazine—CYP2B6—female reproductive system—breast cancer	0.000209	0.0069	CbGeAlD
Promethazine—CYP2C9—female reproductive system—breast cancer	0.000207	0.00683	CbGeAlD
Promethazine—HRH1—female reproductive system—breast cancer	0.000204	0.00673	CbGeAlD
Promethazine—CYP2B6—adrenal gland—breast cancer	0.000204	0.00673	CbGeAlD
Promethazine—HRH1—adrenal gland—breast cancer	0.000199	0.00657	CbGeAlD
Promethazine—HTR2A—pituitary gland—breast cancer	0.000186	0.00614	CbGeAlD
Promethazine—HRH1—female gonad—breast cancer	0.000186	0.00613	CbGeAlD
Promethazine—ABCB1—embryo—breast cancer	0.000185	0.00608	CbGeAlD
Promethazine—CYP2B6—endocrine gland—breast cancer	0.000177	0.00583	CbGeAlD
Promethazine—CYP2C9—endocrine gland—breast cancer	0.000175	0.00578	CbGeAlD
Promethazine—HRH1—endocrine gland—breast cancer	0.000173	0.0057	CbGeAlD
Promethazine—HTR2A—female reproductive system—breast cancer	0.000171	0.00562	CbGeAlD
Promethazine—HTR2A—adrenal gland—breast cancer	0.000167	0.00549	CbGeAlD
Promethazine—CALM2—lymph node—breast cancer	0.000165	0.00543	CbGeAlD
Promethazine—CALM1—lymph node—breast cancer	0.000164	0.0054	CbGeAlD
Promethazine—CYP2D6—female reproductive system—breast cancer	0.000156	0.00512	CbGeAlD
Promethazine—ABCB1—epithelium—breast cancer	0.000151	0.00496	CbGeAlD
Promethazine—HTR2A—endocrine gland—breast cancer	0.000144	0.00476	CbGeAlD
Promethazine—CYP2D6—female gonad—breast cancer	0.000142	0.00466	CbGeAlD
Promethazine—ABCB1—endometrium—breast cancer	0.000135	0.00445	CbGeAlD
Promethazine—CYP2D6—endocrine gland—breast cancer	0.000132	0.00434	CbGeAlD
Promethazine—ABCB1—uterus—breast cancer	0.000124	0.0041	CbGeAlD
Promethazine—ABCB1—pituitary gland—breast cancer	0.000122	0.00403	CbGeAlD
Promethazine—ABCB1—adipose tissue—breast cancer	0.000122	0.00401	CbGeAlD
Promethazine—HRH1—lymph node—breast cancer	0.00012	0.00394	CbGeAlD
Promethazine—ABCB1—female reproductive system—breast cancer	0.000112	0.00369	CbGeAlD
Promethazine—ABCB1—adrenal gland—breast cancer	0.000109	0.0036	CbGeAlD
Promethazine—ABCB1—bone marrow—breast cancer	0.000106	0.00348	CbGeAlD
Promethazine—ABCB1—female gonad—breast cancer	0.000102	0.00335	CbGeAlD
Promethazine—Ethopropazine—BCHE—breast cancer	9.62e-05	0.0332	CrCbGaD
Promethazine—ABCB1—endocrine gland—breast cancer	9.47e-05	0.00312	CbGeAlD
Promethazine—Orphenadrine—SCN10A—breast cancer	8.46e-05	0.0292	CrCbGaD
Promethazine—Levomethadyl Acetate—CYP19A1—breast cancer	8.26e-05	0.0285	CrCbGaD
Promethazine—Clomipramine—GSTP1—breast cancer	8.07e-05	0.0279	CrCbGaD
Promethazine—Triflupromazine—BCHE—breast cancer	7.88e-05	0.0272	CrCbGaD
Promethazine—Constipation—Irinotecan—breast cancer	7.25e-05	0.000686	CcSEcCtD
Promethazine—Pain—Irinotecan—breast cancer	7.25e-05	0.000686	CcSEcCtD
Promethazine—Rash—Goserelin—breast cancer	7.24e-05	0.000684	CcSEcCtD
Promethazine—Dermatitis—Goserelin—breast cancer	7.23e-05	0.000684	CcSEcCtD
Promethazine—Somnolence—Fluorouracil—breast cancer	7.22e-05	0.000683	CcSEcCtD
Promethazine—Headache—Goserelin—breast cancer	7.19e-05	0.00068	CcSEcCtD
Promethazine—Anxiety—Paclitaxel—breast cancer	7.19e-05	0.00068	CcSEcCtD
Promethazine—Erythema—Docetaxel—breast cancer	7.18e-05	0.000679	CcSEcCtD
Promethazine—Decreased appetite—Gemcitabine—breast cancer	7.18e-05	0.000679	CcSEcCtD
Promethazine—Dyspepsia—Fluorouracil—breast cancer	7.15e-05	0.000676	CcSEcCtD
Promethazine—Arrhythmia—Capecitabine—breast cancer	7.14e-05	0.000675	CcSEcCtD
Promethazine—Fatigue—Gemcitabine—breast cancer	7.12e-05	0.000673	CcSEcCtD
Promethazine—Constipation—Gemcitabine—breast cancer	7.07e-05	0.000668	CcSEcCtD
Promethazine—Pain—Gemcitabine—breast cancer	7.07e-05	0.000668	CcSEcCtD
Promethazine—Decreased appetite—Fluorouracil—breast cancer	7.06e-05	0.000667	CcSEcCtD
Promethazine—Dry mouth—Paclitaxel—breast cancer	7.06e-05	0.000667	CcSEcCtD
Promethazine—Asthenia—Thiotepa—breast cancer	7.05e-05	0.000666	CcSEcCtD
Promethazine—Diarrhoea—Vinorelbine—breast cancer	7.04e-05	0.000665	CcSEcCtD
Promethazine—Feeling abnormal—Mitoxantrone—breast cancer	6.99e-05	0.000661	CcSEcCtD
Promethazine—Feeling abnormal—Irinotecan—breast cancer	6.99e-05	0.000661	CcSEcCtD
Promethazine—Confusional state—Paclitaxel—breast cancer	6.98e-05	0.000659	CcSEcCtD
Promethazine—Erythema—Capecitabine—breast cancer	6.96e-05	0.000657	CcSEcCtD
Promethazine—Asthma—Epirubicin—breast cancer	6.95e-05	0.000657	CcSEcCtD
Promethazine—Pruritus—Thiotepa—breast cancer	6.95e-05	0.000657	CcSEcCtD
Promethazine—Pain—Fluorouracil—breast cancer	6.95e-05	0.000657	CcSEcCtD
Promethazine—Anaphylactic shock—Paclitaxel—breast cancer	6.92e-05	0.000654	CcSEcCtD
Promethazine—Oedema—Paclitaxel—breast cancer	6.92e-05	0.000654	CcSEcCtD
Promethazine—Muscle spasms—Docetaxel—breast cancer	6.91e-05	0.000653	CcSEcCtD
Promethazine—Feeling abnormal—Gemcitabine—breast cancer	6.81e-05	0.000643	CcSEcCtD
Promethazine—Shock—Paclitaxel—breast cancer	6.81e-05	0.000643	CcSEcCtD
Promethazine—Dizziness—Vinorelbine—breast cancer	6.8e-05	0.000643	CcSEcCtD
Promethazine—Photosensitivity reaction—Methotrexate—breast cancer	6.78e-05	0.000641	CcSEcCtD
Promethazine—Thrombocytopenia—Paclitaxel—breast cancer	6.77e-05	0.00064	CcSEcCtD
Promethazine—Tachycardia—Paclitaxel—breast cancer	6.75e-05	0.000638	CcSEcCtD
Promethazine—Diarrhoea—Thiotepa—breast cancer	6.72e-05	0.000635	CcSEcCtD
Promethazine—Feeling abnormal—Fluorouracil—breast cancer	6.69e-05	0.000633	CcSEcCtD
Promethazine—Muscle spasms—Capecitabine—breast cancer	6.69e-05	0.000632	CcSEcCtD
Promethazine—Drowsiness—Methotrexate—breast cancer	6.63e-05	0.000626	CcSEcCtD
Promethazine—Depression—Methotrexate—breast cancer	6.61e-05	0.000624	CcSEcCtD
Promethazine—Vision blurred—Capecitabine—breast cancer	6.56e-05	0.00062	CcSEcCtD
Promethazine—ABCB1—lymph node—breast cancer	6.54e-05	0.00216	CbGeAlD
Promethazine—Tremor—Capecitabine—breast cancer	6.52e-05	0.000616	CcSEcCtD
Promethazine—Dizziness—Thiotepa—breast cancer	6.49e-05	0.000614	CcSEcCtD
Promethazine—Rash—Vinorelbine—breast cancer	6.48e-05	0.000613	CcSEcCtD
Promethazine—Dermatitis—Vinorelbine—breast cancer	6.48e-05	0.000612	CcSEcCtD
Promethazine—Hypotension—Paclitaxel—breast cancer	6.46e-05	0.000611	CcSEcCtD
Promethazine—Headache—Vinorelbine—breast cancer	6.44e-05	0.000609	CcSEcCtD
Promethazine—Syncope—Docetaxel—breast cancer	6.44e-05	0.000609	CcSEcCtD
Promethazine—Asthma—Doxorubicin—breast cancer	6.43e-05	0.000608	CcSEcCtD
Promethazine—Leukopenia—Docetaxel—breast cancer	6.43e-05	0.000608	CcSEcCtD
Promethazine—Palpitations—Docetaxel—breast cancer	6.35e-05	0.0006	CcSEcCtD
Promethazine—Photosensitivity reaction—Epirubicin—breast cancer	6.35e-05	0.0006	CcSEcCtD
Promethazine—Loss of consciousness—Docetaxel—breast cancer	6.31e-05	0.000597	CcSEcCtD
Promethazine—Insomnia—Paclitaxel—breast cancer	6.26e-05	0.000591	CcSEcCtD
Promethazine—Syncope—Capecitabine—breast cancer	6.24e-05	0.00059	CcSEcCtD
Promethazine—Leukopenia—Capecitabine—breast cancer	6.23e-05	0.000588	CcSEcCtD
Promethazine—Convulsion—Docetaxel—breast cancer	6.22e-05	0.000588	CcSEcCtD
Promethazine—Drowsiness—Epirubicin—breast cancer	6.2e-05	0.000586	CcSEcCtD
Promethazine—Rash—Thiotepa—breast cancer	6.19e-05	0.000585	CcSEcCtD
Promethazine—Dermatitis—Thiotepa—breast cancer	6.19e-05	0.000585	CcSEcCtD
Promethazine—Agranulocytosis—Methotrexate—breast cancer	6.18e-05	0.000584	CcSEcCtD
Promethazine—Headache—Thiotepa—breast cancer	6.15e-05	0.000582	CcSEcCtD
Promethazine—Somnolence—Paclitaxel—breast cancer	6.15e-05	0.000581	CcSEcCtD
Promethazine—Palpitations—Capecitabine—breast cancer	6.15e-05	0.000581	CcSEcCtD
Promethazine—Loss of consciousness—Capecitabine—breast cancer	6.11e-05	0.000578	CcSEcCtD
Promethazine—Dyspepsia—Paclitaxel—breast cancer	6.09e-05	0.000575	CcSEcCtD
Promethazine—Asthenia—Mitoxantrone—breast cancer	6.09e-05	0.000575	CcSEcCtD
Promethazine—Asthenia—Irinotecan—breast cancer	6.09e-05	0.000575	CcSEcCtD
Promethazine—Jaundice—Epirubicin—breast cancer	6.04e-05	0.000571	CcSEcCtD
Promethazine—Decreased appetite—Paclitaxel—breast cancer	6.01e-05	0.000568	CcSEcCtD
Promethazine—Dry mouth—Docetaxel—breast cancer	5.98e-05	0.000565	CcSEcCtD
Promethazine—Fatigue—Paclitaxel—breast cancer	5.96e-05	0.000564	CcSEcCtD
Promethazine—Asthenia—Gemcitabine—breast cancer	5.93e-05	0.00056	CcSEcCtD
Promethazine—Pain—Paclitaxel—breast cancer	5.92e-05	0.000559	CcSEcCtD
Promethazine—Constipation—Paclitaxel—breast cancer	5.92e-05	0.000559	CcSEcCtD
Promethazine—Confusional state—Docetaxel—breast cancer	5.91e-05	0.000559	CcSEcCtD
Promethazine—Anxiety—Capecitabine—breast cancer	5.9e-05	0.000558	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—breast cancer	5.87e-05	0.000555	CcSEcCtD
Promethazine—Anaphylactic shock—Docetaxel—breast cancer	5.86e-05	0.000554	CcSEcCtD
Promethazine—Oedema—Docetaxel—breast cancer	5.86e-05	0.000554	CcSEcCtD
Promethazine—Pruritus—Gemcitabine—breast cancer	5.85e-05	0.000552	CcSEcCtD
Promethazine—Diarrhoea—Mitoxantrone—breast cancer	5.8e-05	0.000548	CcSEcCtD
Promethazine—Diarrhoea—Irinotecan—breast cancer	5.8e-05	0.000548	CcSEcCtD
Promethazine—Dry mouth—Capecitabine—breast cancer	5.79e-05	0.000547	CcSEcCtD
Promethazine—Cyclobenzaprine—CYP2D6—breast cancer	5.79e-05	0.02	CrCbGaD
Promethazine—Agranulocytosis—Epirubicin—breast cancer	5.79e-05	0.000547	CcSEcCtD
Promethazine—Shock—Docetaxel—breast cancer	5.77e-05	0.000545	CcSEcCtD
Promethazine—Pruritus—Fluorouracil—breast cancer	5.75e-05	0.000543	CcSEcCtD
Promethazine—Thrombocytopenia—Docetaxel—breast cancer	5.74e-05	0.000543	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—breast cancer	5.74e-05	0.000542	CcSEcCtD
Promethazine—Confusional state—Capecitabine—breast cancer	5.72e-05	0.000541	CcSEcCtD
Promethazine—Tachycardia—Docetaxel—breast cancer	5.72e-05	0.000541	CcSEcCtD
Promethazine—Feeling abnormal—Paclitaxel—breast cancer	5.7e-05	0.000539	CcSEcCtD
Promethazine—Oedema—Capecitabine—breast cancer	5.68e-05	0.000537	CcSEcCtD
Promethazine—Bradycardia—Epirubicin—breast cancer	5.67e-05	0.000536	CcSEcCtD
Promethazine—Diarrhoea—Gemcitabine—breast cancer	5.65e-05	0.000534	CcSEcCtD
Promethazine—Dizziness—Irinotecan—breast cancer	5.61e-05	0.00053	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—breast cancer	5.59e-05	0.000529	CcSEcCtD
Promethazine—Shock—Capecitabine—breast cancer	5.59e-05	0.000528	CcSEcCtD
Promethazine—Diarrhoea—Fluorouracil—breast cancer	5.56e-05	0.000525	CcSEcCtD
Promethazine—Thrombocytopenia—Capecitabine—breast cancer	5.56e-05	0.000525	CcSEcCtD
Promethazine—Tinnitus—Methotrexate—breast cancer	5.55e-05	0.000524	CcSEcCtD
Promethazine—Tachycardia—Capecitabine—breast cancer	5.54e-05	0.000524	CcSEcCtD
Promethazine—Hypotension—Docetaxel—breast cancer	5.48e-05	0.000518	CcSEcCtD
Promethazine—Mequitazine—CYP2D6—breast cancer	5.41e-05	0.0187	CrCbGaD
Promethazine—Alimemazine—CYP3A4—breast cancer	5.39e-05	0.0186	CrCbGaD
Promethazine—Dizziness—Fluorouracil—breast cancer	5.37e-05	0.000508	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—breast cancer	5.35e-05	0.000506	CcSEcCtD
Promethazine—Rash—Mitoxantrone—breast cancer	5.35e-05	0.000505	CcSEcCtD
Promethazine—Rash—Irinotecan—breast cancer	5.35e-05	0.000505	CcSEcCtD
Promethazine—Dermatitis—Mitoxantrone—breast cancer	5.34e-05	0.000505	CcSEcCtD
Promethazine—Dermatitis—Irinotecan—breast cancer	5.34e-05	0.000505	CcSEcCtD
Promethazine—Headache—Mitoxantrone—breast cancer	5.31e-05	0.000502	CcSEcCtD
Promethazine—Headache—Irinotecan—breast cancer	5.31e-05	0.000502	CcSEcCtD
Promethazine—Hypotension—Capecitabine—breast cancer	5.3e-05	0.000501	CcSEcCtD
Promethazine—Insomnia—Docetaxel—breast cancer	5.3e-05	0.000501	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—breast cancer	5.24e-05	0.000496	CcSEcCtD
Promethazine—Somnolence—Docetaxel—breast cancer	5.21e-05	0.000493	CcSEcCtD
Promethazine—Rash—Gemcitabine—breast cancer	5.21e-05	0.000492	CcSEcCtD
Promethazine—Dermatitis—Gemcitabine—breast cancer	5.2e-05	0.000492	CcSEcCtD
Promethazine—Tinnitus—Epirubicin—breast cancer	5.19e-05	0.000491	CcSEcCtD
Promethazine—Erythema—Methotrexate—breast cancer	5.18e-05	0.000489	CcSEcCtD
Promethazine—Headache—Gemcitabine—breast cancer	5.18e-05	0.000489	CcSEcCtD
Promethazine—Dyspepsia—Docetaxel—breast cancer	5.16e-05	0.000488	CcSEcCtD
Promethazine—Insomnia—Capecitabine—breast cancer	5.13e-05	0.000485	CcSEcCtD
Promethazine—Rash—Fluorouracil—breast cancer	5.12e-05	0.000484	CcSEcCtD
Promethazine—Dermatitis—Fluorouracil—breast cancer	5.12e-05	0.000484	CcSEcCtD
Promethazine—Decreased appetite—Docetaxel—breast cancer	5.1e-05	0.000482	CcSEcCtD
Promethazine—Headache—Fluorouracil—breast cancer	5.09e-05	0.000481	CcSEcCtD
Promethazine—Fatigue—Docetaxel—breast cancer	5.06e-05	0.000478	CcSEcCtD
Promethazine—Constipation—Docetaxel—breast cancer	5.01e-05	0.000474	CcSEcCtD
Promethazine—Pain—Docetaxel—breast cancer	5.01e-05	0.000474	CcSEcCtD
Promethazine—Dyspepsia—Capecitabine—breast cancer	5e-05	0.000472	CcSEcCtD
Promethazine—Arrhythmia—Epirubicin—breast cancer	4.97e-05	0.00047	CcSEcCtD
Promethazine—Cyclobenzaprine—CYP3A4—breast cancer	4.96e-05	0.0171	CrCbGaD
Promethazine—Asthenia—Paclitaxel—breast cancer	4.96e-05	0.000469	CcSEcCtD
Promethazine—Decreased appetite—Capecitabine—breast cancer	4.93e-05	0.000466	CcSEcCtD
Promethazine—Fatigue—Capecitabine—breast cancer	4.89e-05	0.000463	CcSEcCtD
Promethazine—Pruritus—Paclitaxel—breast cancer	4.89e-05	0.000463	CcSEcCtD
Promethazine—Vision blurred—Methotrexate—breast cancer	4.88e-05	0.000461	CcSEcCtD
Promethazine—Pain—Capecitabine—breast cancer	4.85e-05	0.000459	CcSEcCtD
Promethazine—Constipation—Capecitabine—breast cancer	4.85e-05	0.000459	CcSEcCtD
Promethazine—Diltiazem—CYP2D6—breast cancer	4.85e-05	0.0167	CrCbGaD
Promethazine—Erythema—Epirubicin—breast cancer	4.85e-05	0.000458	CcSEcCtD
Promethazine—Methadone—CYP19A1—breast cancer	4.84e-05	0.0167	CrCbGaD
Promethazine—Feeling abnormal—Docetaxel—breast cancer	4.83e-05	0.000457	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—breast cancer	4.8e-05	0.000454	CcSEcCtD
Promethazine—Tension—Epirubicin—breast cancer	4.76e-05	0.000449	CcSEcCtD
Promethazine—Diarrhoea—Paclitaxel—breast cancer	4.73e-05	0.000447	CcSEcCtD
Promethazine—Nervousness—Epirubicin—breast cancer	4.71e-05	0.000445	CcSEcCtD
Promethazine—Feeling abnormal—Capecitabine—breast cancer	4.68e-05	0.000442	CcSEcCtD
Promethazine—Muscle spasms—Epirubicin—breast cancer	4.66e-05	0.00044	CcSEcCtD
Promethazine—Mequitazine—CYP3A4—breast cancer	4.64e-05	0.016	CrCbGaD
Promethazine—Leukopenia—Methotrexate—breast cancer	4.63e-05	0.000438	CcSEcCtD
Promethazine—Arrhythmia—Doxorubicin—breast cancer	4.6e-05	0.000435	CcSEcCtD
Promethazine—Dizziness—Paclitaxel—breast cancer	4.57e-05	0.000432	CcSEcCtD
Promethazine—Vision blurred—Epirubicin—breast cancer	4.57e-05	0.000432	CcSEcCtD
Promethazine—Oxcarbazepine—CYP3A4—breast cancer	4.54e-05	0.0157	CrCbGaD
Promethazine—Convulsion—Methotrexate—breast cancer	4.49e-05	0.000424	CcSEcCtD
Promethazine—Erythema—Doxorubicin—breast cancer	4.48e-05	0.000424	CcSEcCtD
Promethazine—Agitation—Epirubicin—breast cancer	4.45e-05	0.000421	CcSEcCtD
Promethazine—Tension—Doxorubicin—breast cancer	4.4e-05	0.000416	CcSEcCtD
Promethazine—Rash—Paclitaxel—breast cancer	4.36e-05	0.000412	CcSEcCtD
Promethazine—Dermatitis—Paclitaxel—breast cancer	4.36e-05	0.000412	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—breast cancer	4.35e-05	0.000412	CcSEcCtD
Promethazine—Syncope—Epirubicin—breast cancer	4.35e-05	0.000411	CcSEcCtD
Promethazine—Leukopenia—Epirubicin—breast cancer	4.34e-05	0.00041	CcSEcCtD
Promethazine—Headache—Paclitaxel—breast cancer	4.33e-05	0.00041	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—breast cancer	4.31e-05	0.000407	CcSEcCtD
Promethazine—Palpitations—Epirubicin—breast cancer	4.28e-05	0.000405	CcSEcCtD
Promethazine—Confusional state—Methotrexate—breast cancer	4.26e-05	0.000403	CcSEcCtD
Promethazine—Loss of consciousness—Epirubicin—breast cancer	4.26e-05	0.000403	CcSEcCtD
Promethazine—Anaphylactic shock—Methotrexate—breast cancer	4.23e-05	0.000399	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—breast cancer	4.23e-05	0.000399	CcSEcCtD
Promethazine—Asthenia—Docetaxel—breast cancer	4.21e-05	0.000398	CcSEcCtD
Promethazine—Convulsion—Epirubicin—breast cancer	4.2e-05	0.000397	CcSEcCtD
Promethazine—Diltiazem—CYP3A4—breast cancer	4.16e-05	0.0144	CrCbGaD
Promethazine—Pruritus—Docetaxel—breast cancer	4.15e-05	0.000392	CcSEcCtD
Promethazine—Thrombocytopenia—Methotrexate—breast cancer	4.14e-05	0.000391	CcSEcCtD
Promethazine—Agitation—Doxorubicin—breast cancer	4.12e-05	0.000389	CcSEcCtD
Promethazine—Anxiety—Epirubicin—breast cancer	4.11e-05	0.000389	CcSEcCtD
Promethazine—Asthenia—Capecitabine—breast cancer	4.07e-05	0.000385	CcSEcCtD
Promethazine—Diphenhydramine—PTGS1—breast cancer	4.04e-05	0.0139	CrCbGaD
Promethazine—Dry mouth—Epirubicin—breast cancer	4.03e-05	0.000381	CcSEcCtD
Promethazine—Syncope—Doxorubicin—breast cancer	4.02e-05	0.00038	CcSEcCtD
Promethazine—Pruritus—Capecitabine—breast cancer	4.02e-05	0.00038	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—breast cancer	4.01e-05	0.000379	CcSEcCtD
Promethazine—Diarrhoea—Docetaxel—breast cancer	4.01e-05	0.000379	CcSEcCtD
Promethazine—Confusional state—Epirubicin—breast cancer	3.99e-05	0.000377	CcSEcCtD
Promethazine—Palpitations—Doxorubicin—breast cancer	3.96e-05	0.000374	CcSEcCtD
Promethazine—Oxcarbazepine—ALB—breast cancer	3.96e-05	0.0137	CrCbGaD
Promethazine—Anaphylactic shock—Epirubicin—breast cancer	3.95e-05	0.000374	CcSEcCtD
Promethazine—Oedema—Epirubicin—breast cancer	3.95e-05	0.000374	CcSEcCtD
Promethazine—Hypotension—Methotrexate—breast cancer	3.95e-05	0.000373	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—breast cancer	3.94e-05	0.000372	CcSEcCtD
Promethazine—Shock—Epirubicin—breast cancer	3.89e-05	0.000368	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—breast cancer	3.88e-05	0.000367	CcSEcCtD
Promethazine—Diarrhoea—Capecitabine—breast cancer	3.88e-05	0.000367	CcSEcCtD
Promethazine—Levomethadyl Acetate—CYP3A4—breast cancer	3.88e-05	0.0134	CrCbGaD
Promethazine—Dizziness—Docetaxel—breast cancer	3.88e-05	0.000366	CcSEcCtD
Promethazine—Thrombocytopenia—Epirubicin—breast cancer	3.87e-05	0.000366	CcSEcCtD
Promethazine—Tachycardia—Epirubicin—breast cancer	3.86e-05	0.000365	CcSEcCtD
Promethazine—Pipotiazine—CYP2D6—breast cancer	3.85e-05	0.0133	CrCbGaD
Promethazine—Insomnia—Methotrexate—breast cancer	3.82e-05	0.000361	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—breast cancer	3.8e-05	0.00036	CcSEcCtD
Promethazine—Chlorpromazine—BCHE—breast cancer	3.8e-05	0.0131	CrCbGaD
Promethazine—Mesoridazine—CYP2D6—breast cancer	3.8e-05	0.0131	CrCbGaD
Promethazine—Somnolence—Methotrexate—breast cancer	3.76e-05	0.000355	CcSEcCtD
Promethazine—Dizziness—Capecitabine—breast cancer	3.75e-05	0.000355	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—breast cancer	3.73e-05	0.000353	CcSEcCtD
Promethazine—Dyspepsia—Methotrexate—breast cancer	3.72e-05	0.000352	CcSEcCtD
Promethazine—Rash—Docetaxel—breast cancer	3.7e-05	0.000349	CcSEcCtD
Promethazine—Hypotension—Epirubicin—breast cancer	3.7e-05	0.000349	CcSEcCtD
Promethazine—Dermatitis—Docetaxel—breast cancer	3.69e-05	0.000349	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—breast cancer	3.69e-05	0.000349	CcSEcCtD
Promethazine—Prochlorperazine—CYP2D6—breast cancer	3.68e-05	0.0127	CrCbGaD
Promethazine—Decreased appetite—Methotrexate—breast cancer	3.67e-05	0.000347	CcSEcCtD
Promethazine—Headache—Docetaxel—breast cancer	3.67e-05	0.000347	CcSEcCtD
Promethazine—Oedema—Doxorubicin—breast cancer	3.66e-05	0.000346	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—breast cancer	3.66e-05	0.000346	CcSEcCtD
Promethazine—Fatigue—Methotrexate—breast cancer	3.64e-05	0.000344	CcSEcCtD
Promethazine—Pain—Methotrexate—breast cancer	3.61e-05	0.000342	CcSEcCtD
Promethazine—Shock—Doxorubicin—breast cancer	3.6e-05	0.00034	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—breast cancer	3.58e-05	0.000339	CcSEcCtD
Promethazine—Rash—Capecitabine—breast cancer	3.58e-05	0.000338	CcSEcCtD
Promethazine—Insomnia—Epirubicin—breast cancer	3.58e-05	0.000338	CcSEcCtD
Promethazine—Dermatitis—Capecitabine—breast cancer	3.58e-05	0.000338	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—breast cancer	3.57e-05	0.000338	CcSEcCtD
Promethazine—Headache—Capecitabine—breast cancer	3.56e-05	0.000336	CcSEcCtD
Promethazine—Somnolence—Epirubicin—breast cancer	3.52e-05	0.000332	CcSEcCtD
Promethazine—Feeling abnormal—Methotrexate—breast cancer	3.48e-05	0.000329	CcSEcCtD
Promethazine—Dyspepsia—Epirubicin—breast cancer	3.48e-05	0.000329	CcSEcCtD
Promethazine—Diltiazem—ABCB1—breast cancer	3.46e-05	0.012	CrCbGaD
Promethazine—Decreased appetite—Epirubicin—breast cancer	3.44e-05	0.000325	CcSEcCtD
Promethazine—Hypotension—Doxorubicin—breast cancer	3.42e-05	0.000323	CcSEcCtD
Promethazine—Fatigue—Epirubicin—breast cancer	3.41e-05	0.000322	CcSEcCtD
Promethazine—Constipation—Epirubicin—breast cancer	3.38e-05	0.00032	CcSEcCtD
Promethazine—Pain—Epirubicin—breast cancer	3.38e-05	0.00032	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—breast cancer	3.31e-05	0.000313	CcSEcCtD
Promethazine—Pipotiazine—CYP3A4—breast cancer	3.3e-05	0.0114	CrCbGaD
Promethazine—Feeling abnormal—Epirubicin—breast cancer	3.26e-05	0.000308	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—breast cancer	3.25e-05	0.000307	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—breast cancer	3.22e-05	0.000304	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—breast cancer	3.18e-05	0.000301	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—breast cancer	3.15e-05	0.000298	CcSEcCtD
Promethazine—Prochlorperazine—CYP3A4—breast cancer	3.15e-05	0.0109	CrCbGaD
Promethazine—Pain—Doxorubicin—breast cancer	3.13e-05	0.000296	CcSEcCtD
Promethazine—Constipation—Doxorubicin—breast cancer	3.13e-05	0.000296	CcSEcCtD
Promethazine—Carbamazepine—CYP3A4—breast cancer	3.09e-05	0.0107	CrCbGaD
Promethazine—Triflupromazine—ABCB1—breast cancer	3.09e-05	0.0107	CrCbGaD
Promethazine—Clomipramine—CYP2D6—breast cancer	3.04e-05	0.0105	CrCbGaD
Promethazine—Asthenia—Methotrexate—breast cancer	3.03e-05	0.000287	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—breast cancer	3.02e-05	0.000285	CcSEcCtD
Promethazine—Acepromazine—ALB—breast cancer	2.99e-05	0.0103	CrCbGaD
Promethazine—Pruritus—Methotrexate—breast cancer	2.99e-05	0.000283	CcSEcCtD
Promethazine—Benzphetamine—CYP3A4—breast cancer	2.94e-05	0.0101	CrCbGaD
Promethazine—Thioproperazine—ALB—breast cancer	2.93e-05	0.0101	CrCbGaD
Promethazine—Diarrhoea—Methotrexate—breast cancer	2.89e-05	0.000273	CcSEcCtD
Promethazine—Pipotiazine—ALB—breast cancer	2.88e-05	0.00993	CrCbGaD
Promethazine—Thioridazine—CYP2D6—breast cancer	2.86e-05	0.00989	CrCbGaD
Promethazine—Asthenia—Epirubicin—breast cancer	2.84e-05	0.000268	CcSEcCtD
Promethazine—Pruritus—Epirubicin—breast cancer	2.8e-05	0.000264	CcSEcCtD
Promethazine—Trimipramine—CYP2D6—breast cancer	2.8e-05	0.00966	CrCbGaD
Promethazine—Dizziness—Methotrexate—breast cancer	2.79e-05	0.000264	CcSEcCtD
Promethazine—Diphenhydramine—CYP2D6—breast cancer	2.75e-05	0.00948	CrCbGaD
Promethazine—Methotrimeprazine—CYP2D6—breast cancer	2.73e-05	0.00944	CrCbGaD
Promethazine—Diarrhoea—Epirubicin—breast cancer	2.71e-05	0.000256	CcSEcCtD
Promethazine—Doxepin—CYP2D6—breast cancer	2.67e-05	0.0092	CrCbGaD
Promethazine—Rash—Methotrexate—breast cancer	2.66e-05	0.000252	CcSEcCtD
Promethazine—Dermatitis—Methotrexate—breast cancer	2.66e-05	0.000252	CcSEcCtD
Promethazine—Methadone—CYP2D6—breast cancer	2.65e-05	0.00915	CrCbGaD
Promethazine—Headache—Methotrexate—breast cancer	2.65e-05	0.00025	CcSEcCtD
Promethazine—Perphenazine—CYP2D6—breast cancer	2.63e-05	0.00907	CrCbGaD
Promethazine—Asthenia—Doxorubicin—breast cancer	2.63e-05	0.000248	CcSEcCtD
Promethazine—Dizziness—Epirubicin—breast cancer	2.62e-05	0.000247	CcSEcCtD
Promethazine—Clomipramine—CYP3A4—breast cancer	2.61e-05	0.009	CrCbGaD
Promethazine—Pruritus—Doxorubicin—breast cancer	2.59e-05	0.000245	CcSEcCtD
Promethazine—Carbamazepine—ABCB1—breast cancer	2.58e-05	0.00889	CrCbGaD
Promethazine—Diarrhoea—Doxorubicin—breast cancer	2.5e-05	0.000237	CcSEcCtD
Promethazine—Rash—Epirubicin—breast cancer	2.49e-05	0.000236	CcSEcCtD
Promethazine—Dermatitis—Epirubicin—breast cancer	2.49e-05	0.000235	CcSEcCtD
Promethazine—Headache—Epirubicin—breast cancer	2.48e-05	0.000234	CcSEcCtD
Promethazine—Desipramine—CYP2D6—breast cancer	2.45e-05	0.00844	CrCbGaD
Promethazine—Dizziness—Doxorubicin—breast cancer	2.42e-05	0.000229	CcSEcCtD
Promethazine—Trimipramine—CYP3A4—breast cancer	2.4e-05	0.00828	CrCbGaD
Promethazine—Rash—Doxorubicin—breast cancer	2.31e-05	0.000218	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—breast cancer	2.31e-05	0.000218	CcSEcCtD
Promethazine—Headache—Doxorubicin—breast cancer	2.29e-05	0.000217	CcSEcCtD
Promethazine—Doxepin—CYP3A4—breast cancer	2.29e-05	0.00789	CrCbGaD
Promethazine—Clomipramine—ALB—breast cancer	2.27e-05	0.00785	CrCbGaD
Promethazine—Methadone—CYP3A4—breast cancer	2.27e-05	0.00785	CrCbGaD
Promethazine—Perphenazine—CYP3A4—breast cancer	2.25e-05	0.00778	CrCbGaD
Promethazine—Orphenadrine—CYP3A4—breast cancer	2.23e-05	0.00769	CrCbGaD
Promethazine—Clomipramine—ABCB1—breast cancer	2.17e-05	0.00749	CrCbGaD
Promethazine—Chlorprothixene—ABCB1—breast cancer	2.16e-05	0.00746	CrCbGaD
Promethazine—Desipramine—CYP3A4—breast cancer	2.1e-05	0.00724	CrCbGaD
Promethazine—Chlorpromazine—CYP2D6—breast cancer	2.09e-05	0.0072	CrCbGaD
Promethazine—Imipramine—CYP2D6—breast cancer	2.07e-05	0.00716	CrCbGaD
Promethazine—Amitriptyline—CYP2D6—breast cancer	2.06e-05	0.00712	CrCbGaD
Promethazine—Promazine—CYP3A4—breast cancer	2.03e-05	0.00702	CrCbGaD
Promethazine—Trimipramine—ABCB1—breast cancer	2e-05	0.00689	CrCbGaD
Promethazine—Doxepin—ABCB1—breast cancer	1.9e-05	0.00657	CrCbGaD
Promethazine—Trifluoperazine—ABCB1—breast cancer	1.9e-05	0.00655	CrCbGaD
Promethazine—Methadone—ABCB1—breast cancer	1.89e-05	0.00654	CrCbGaD
Promethazine—Chlorpromazine—CYP3A4—breast cancer	1.79e-05	0.00617	CrCbGaD
Promethazine—Imipramine—CYP3A4—breast cancer	1.78e-05	0.00614	CrCbGaD
Promethazine—Amitriptyline—CYP3A4—breast cancer	1.77e-05	0.0061	CrCbGaD
Promethazine—Desipramine—ABCB1—breast cancer	1.75e-05	0.00603	CrCbGaD
Promethazine—Chlorpromazine—ALB—breast cancer	1.56e-05	0.00539	CrCbGaD
Promethazine—Amitriptyline—ALB—breast cancer	1.54e-05	0.00532	CrCbGaD
Promethazine—Chlorpromazine—ABCB1—breast cancer	1.49e-05	0.00514	CrCbGaD
Promethazine—Imipramine—ABCB1—breast cancer	1.48e-05	0.00511	CrCbGaD
Promethazine—Amitriptyline—ABCB1—breast cancer	1.47e-05	0.00508	CrCbGaD
Promethazine—CALM2—Signaling Pathways—RAF1—breast cancer	9.83e-07	9.36e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RAF1—breast cancer	9.83e-07	9.36e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—TGFB1—breast cancer	9.82e-07	9.34e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—TGFB1—breast cancer	9.82e-07	9.34e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RELA—breast cancer	9.79e-07	9.32e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RELA—breast cancer	9.79e-07	9.32e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—NOS3—breast cancer	9.75e-07	9.27e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—SRC—breast cancer	9.74e-07	9.26e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB2—breast cancer	9.73e-07	9.26e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB2—breast cancer	9.73e-07	9.26e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CD—breast cancer	9.73e-07	9.25e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CD—breast cancer	9.64e-07	9.17e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—breast cancer	9.63e-07	9.16e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—breast cancer	9.63e-07	9.16e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MTOR—breast cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CB—breast cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CB—breast cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MTOR—breast cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—ALB—breast cancer	9.6e-07	9.13e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—SRC—breast cancer	9.58e-07	9.12e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—SRC—breast cancer	9.56e-07	9.1e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CXCL8—breast cancer	9.54e-07	9.07e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—SRC—breast cancer	9.53e-07	9.07e-06	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—breast cancer	9.53e-07	9.06e-06	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—IL6—breast cancer	9.52e-07	9.06e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—ALB—breast cancer	9.52e-07	9.06e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—SRC—breast cancer	9.5e-07	9.04e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—breast cancer	9.48e-07	9.02e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—breast cancer	9.48e-07	9.02e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—SRC—breast cancer	9.41e-07	8.95e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—breast cancer	9.41e-07	8.95e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—breast cancer	9.39e-07	8.93e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—SRC—breast cancer	9.38e-07	8.93e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—breast cancer	9.36e-07	8.9e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—breast cancer	9.33e-07	8.88e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1B—breast cancer	9.31e-07	8.86e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—breast cancer	9.31e-07	8.86e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—breast cancer	9.28e-07	8.83e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—breast cancer	9.25e-07	8.8e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—breast cancer	9.24e-07	8.79e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CXCL8—breast cancer	9.23e-07	8.78e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CXCL8—breast cancer	9.23e-07	8.78e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—breast cancer	9.22e-07	8.77e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—breast cancer	9.19e-07	8.74e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—NOS3—breast cancer	9.18e-07	8.74e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—breast cancer	9.17e-07	8.72e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—breast cancer	9.17e-07	8.72e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—breast cancer	9.16e-07	8.72e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—breast cancer	9.16e-07	8.72e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	9.14e-07	8.69e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CASP3—breast cancer	9.13e-07	8.69e-06	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—IL6—breast cancer	9.12e-07	8.67e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—breast cancer	9.12e-07	8.67e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—NOS3—breast cancer	9.1e-07	8.66e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—breast cancer	9.1e-07	8.66e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—breast cancer	9.1e-07	8.66e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—breast cancer	9.07e-07	8.63e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—IL6—breast cancer	9.07e-07	8.63e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—breast cancer	9.05e-07	8.61e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—breast cancer	9.05e-07	8.61e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—breast cancer	9.05e-07	8.61e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1B—breast cancer	9.01e-07	8.57e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1B—breast cancer	9.01e-07	8.57e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CB—breast cancer	9e-07	8.56e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK3—breast cancer	8.97e-07	8.54e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—breast cancer	8.91e-07	8.48e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—breast cancer	8.89e-07	8.45e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—JUN—breast cancer	8.87e-07	8.44e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CASP3—breast cancer	8.83e-07	8.4e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CASP3—breast cancer	8.83e-07	8.4e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK3—breast cancer	8.83e-07	8.4e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—breast cancer	8.82e-07	8.39e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—breast cancer	8.82e-07	8.39e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK3—breast cancer	8.81e-07	8.38e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—breast cancer	8.8e-07	8.37e-06	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—breast cancer	8.78e-07	8.36e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK3—breast cancer	8.78e-07	8.35e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—IL6—breast cancer	8.77e-07	8.35e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—IL6—breast cancer	8.77e-07	8.35e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK3—breast cancer	8.75e-07	8.33e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—breast cancer	8.73e-07	8.3e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TGFB1—breast cancer	8.71e-07	8.28e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK3—breast cancer	8.67e-07	8.25e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—breast cancer	8.66e-07	8.24e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	8.64e-07	8.22e-06	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—breast cancer	8.64e-07	8.22e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—breast cancer	8.64e-07	8.22e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MMP9—breast cancer	8.63e-07	8.21e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1A—breast cancer	8.6e-07	8.18e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—breast cancer	8.6e-07	8.18e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—breast cancer	8.6e-07	8.18e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—breast cancer	8.59e-07	8.17e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—JUN—breast cancer	8.58e-07	8.16e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—JUN—breast cancer	8.58e-07	8.16e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—breast cancer	8.58e-07	8.16e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—breast cancer	8.57e-07	8.15e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TGFB1—breast cancer	8.57e-07	8.15e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TGFB1—breast cancer	8.55e-07	8.13e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—breast cancer	8.54e-07	8.13e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—breast cancer	8.54e-07	8.12e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TGFB1—breast cancer	8.52e-07	8.11e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—breast cancer	8.51e-07	8.1e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—breast cancer	8.51e-07	8.1e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—breast cancer	8.51e-07	8.1e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TGFB1—breast cancer	8.49e-07	8.08e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CB—breast cancer	8.48e-07	8.07e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—breast cancer	8.43e-07	8.02e-06	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—breast cancer	8.41e-07	8e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TGFB1—breast cancer	8.41e-07	8e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—breast cancer	8.41e-07	8e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CB—breast cancer	8.4e-07	8e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—breast cancer	8.4e-07	7.99e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—breast cancer	8.4e-07	7.99e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK8—breast cancer	8.39e-07	7.98e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	8.39e-07	7.98e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—breast cancer	8.38e-07	7.97e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—breast cancer	8.38e-07	7.97e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—breast cancer	8.38e-07	7.97e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—breast cancer	8.37e-07	7.96e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—breast cancer	8.36e-07	7.95e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—breast cancer	8.36e-07	7.95e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—breast cancer	8.35e-07	7.95e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MMP9—breast cancer	8.35e-07	7.94e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MMP9—breast cancer	8.35e-07	7.94e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—breast cancer	8.33e-07	7.92e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—breast cancer	8.33e-07	7.92e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1A—breast cancer	8.32e-07	7.91e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1A—breast cancer	8.32e-07	7.91e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—breast cancer	8.3e-07	7.89e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—breast cancer	8.3e-07	7.89e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—IL6—breast cancer	8.29e-07	7.88e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—breast cancer	8.25e-07	7.85e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—breast cancer	8.22e-07	7.82e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK8—breast cancer	8.12e-07	7.72e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK8—breast cancer	8.12e-07	7.72e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—breast cancer	8.09e-07	7.7e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—breast cancer	8.09e-07	7.7e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—breast cancer	8.06e-07	7.67e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—IL6—breast cancer	8.02e-07	7.63e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—IL6—breast cancer	8.02e-07	7.63e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—breast cancer	7.99e-07	7.61e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—SRC—breast cancer	7.95e-07	7.57e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—breast cancer	7.93e-07	7.55e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—breast cancer	7.92e-07	7.53e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—breast cancer	7.89e-07	7.51e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—breast cancer	7.87e-07	7.48e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—breast cancer	7.79e-07	7.41e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—breast cancer	7.77e-07	7.4e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—breast cancer	7.77e-07	7.39e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—breast cancer	7.75e-07	7.37e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—breast cancer	7.73e-07	7.36e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—breast cancer	7.73e-07	7.36e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—SRC—breast cancer	7.69e-07	7.32e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—SRC—breast cancer	7.69e-07	7.32e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—breast cancer	7.67e-07	7.3e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—IL6—breast cancer	7.65e-07	7.28e-06	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—breast cancer	7.65e-07	7.27e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—breast cancer	7.49e-07	7.13e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—breast cancer	7.49e-07	7.13e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—breast cancer	7.44e-07	7.07e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—breast cancer	7.42e-07	7.06e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—breast cancer	7.42e-07	7.06e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—breast cancer	7.41e-07	7.05e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—IL6—breast cancer	7.4e-07	7.04e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—IL6—breast cancer	7.4e-07	7.04e-06	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—breast cancer	7.4e-07	7.04e-06	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—breast cancer	7.4e-07	7.04e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK3—breast cancer	7.33e-07	6.97e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—breast cancer	7.33e-07	6.97e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—breast cancer	7.29e-07	6.93e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—breast cancer	7.27e-07	6.92e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—breast cancer	7.26e-07	6.91e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—breast cancer	7.25e-07	6.9e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—breast cancer	7.24e-07	6.88e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—breast cancer	7.23e-07	6.88e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—breast cancer	7.17e-07	6.82e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—breast cancer	7.16e-07	6.81e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	7.14e-07	6.79e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—breast cancer	7.13e-07	6.78e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TGFB1—breast cancer	7.11e-07	6.76e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK3—breast cancer	7.09e-07	6.74e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK3—breast cancer	7.09e-07	6.74e-06	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—breast cancer	7.06e-07	6.72e-06	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—breast cancer	7.06e-07	6.72e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—breast cancer	7.05e-07	6.71e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—breast cancer	7.04e-07	6.69e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—breast cancer	7.01e-07	6.67e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—breast cancer	7e-07	6.66e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—breast cancer	7e-07	6.66e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—breast cancer	6.99e-07	6.65e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—breast cancer	6.97e-07	6.63e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—breast cancer	6.92e-07	6.59e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—breast cancer	6.9e-07	6.57e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—breast cancer	6.9e-07	6.56e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—breast cancer	6.9e-07	6.56e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TGFB1—breast cancer	6.88e-07	6.54e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TGFB1—breast cancer	6.88e-07	6.54e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—breast cancer	6.85e-07	6.52e-06	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—breast cancer	6.83e-07	6.5e-06	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—breast cancer	6.83e-07	6.5e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—breast cancer	6.74e-07	6.42e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—breast cancer	6.74e-07	6.42e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—breast cancer	6.74e-07	6.42e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—breast cancer	6.73e-07	6.4e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—breast cancer	6.71e-07	6.38e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—breast cancer	6.69e-07	6.36e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—breast cancer	6.62e-07	6.3e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—breast cancer	6.6e-07	6.28e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—breast cancer	6.59e-07	6.27e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL6—breast cancer	6.56e-07	6.24e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL6—breast cancer	6.45e-07	6.14e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL6—breast cancer	6.44e-07	6.13e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL6—breast cancer	6.42e-07	6.11e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL6—breast cancer	6.4e-07	6.09e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—breast cancer	6.37e-07	6.06e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—breast cancer	6.37e-07	6.06e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL6—breast cancer	6.34e-07	6.03e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL6—breast cancer	6.32e-07	6.01e-06	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—breast cancer	6.07e-07	5.78e-06	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—breast cancer	6.05e-07	5.76e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—breast cancer	6.05e-07	5.76e-06	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—breast cancer	5.95e-07	5.67e-06	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—breast cancer	5.94e-07	5.65e-06	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—breast cancer	5.92e-07	5.63e-06	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—breast cancer	5.91e-07	5.62e-06	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—breast cancer	5.9e-07	5.62e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—breast cancer	5.85e-07	5.57e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—breast cancer	5.85e-07	5.57e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—breast cancer	5.85e-07	5.57e-06	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—breast cancer	5.85e-07	5.56e-06	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—breast cancer	5.83e-07	5.55e-06	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—breast cancer	5.72e-07	5.44e-06	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—breast cancer	5.72e-07	5.44e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—breast cancer	5.66e-07	5.39e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—breast cancer	5.66e-07	5.39e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—breast cancer	5.6e-07	5.33e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—breast cancer	5.48e-07	5.22e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—breast cancer	5.42e-07	5.15e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—breast cancer	5.42e-07	5.15e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL6—breast cancer	5.36e-07	5.1e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL6—breast cancer	5.18e-07	4.93e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL6—breast cancer	5.18e-07	4.93e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—breast cancer	5.17e-07	4.92e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—breast cancer	5.12e-07	4.87e-06	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—breast cancer	4.94e-07	4.7e-06	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—breast cancer	4.78e-07	4.55e-06	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—breast cancer	4.78e-07	4.55e-06	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—breast cancer	4.48e-07	4.26e-06	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—breast cancer	4.22e-07	4.02e-06	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—breast cancer	4.19e-07	3.98e-06	CbGpPWpGaD
